Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12618001240235
ACTRN12618001240235
Withdrawn
Phase 3

For people with Dupuytren's disease of the hand, is treatment with percutaneous fasciotomy as effective as injectable collagenase in improving functionality and fixed flexure angles.

aunceston General Hospital0 sites100 target enrollmentJuly 23, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
aunceston General Hospital
Enrollment
100
Status
Withdrawn
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 23, 2018
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
aunceston General Hospital

Eligibility Criteria

Inclusion Criteria

  • •Dupuytren’s disease with contracture (20\-100 degrees Metacarpo\-phalyngeal (MCP) joint or 20\-80 at the proximal interphalyngeal (PIP) joint.)
  • •Consulting clinician deems it appropriate management for the patient to have one or other of the fasciotomy procedures
  • •No previous treatment within 90 days
  • •Able to provide informed consent; age 18 years and older

Exclusion Criteria

  • •Bleeding disorder, blood thinning treatment (except aspirin 150mg/day)
  • •Allergy to collagenase ; pregnancy, breast feeding; neuromuscular disorders
  • •Administration of tetracyclines, antracyclines or anthraquinones in the past 14 days (these meds inhibit matrix metalloproteinase\-mediate collagen degradation at suprapharmacological concentrations in vitro).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Nodular Shrinking in Dupuytren DiseaseDupuytren's Disease
NCT06321991Universitaire Ziekenhuizen KU Leuven80
Active, not recruiting
Not Applicable
Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant DeviceDupuytren ContractureDupuytren Disease of Palm and Finger
NCT03741764prof. dr. Ilse Degreef20
Completed
Not Applicable
Natural Disease Progress of Dupuytren DiseaseDupuytren ContractureDisease Progression
NCT01923103University Medical Center Groningen261
Withdrawn
Phase 3
Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's DiseaseDupuytren Contracture
NCT01776892University of Alberta
Recruiting
Not Applicable
Micronerves in Dupuytren and the Impact of Its Dissection on RecurrenceDupuytren's Disease
NCT06142929Universitaire Ziekenhuizen KU Leuven80